Patients with BRCA1 variants were more likely than those with BRCA2 variants to receive a diagnosis of breast cancer prior to 40 years of age, were more likely to be premenopausal at breast cancer diagnosis, and tended to have more advanced primary tumors that were more likely to be hormone receptor negative and more likely to be high grade. This evidence concerns the gene BRCA2 and breast carcinoma.